Clinical Trials Directory

Trials / Unknown

UnknownNCT00005105

Genetic Study of Insulin-Like Growth Factor-I Receptor Mutations in Patients With Intrauterine Growth Retardation

Status
Unknown
Phase
Study type
Observational
Enrollment
75 (planned)
Sponsor
National Center for Research Resources (NCRR) · NIH
Sex
All
Age
18 Months – 18 Years
Healthy volunteers
Not accepted

Summary

OBJECTIVES: I. Determine if mutations in the gene encoding the insulin-like growth factor-I receptor lead to relative insulin-like growth factor-I insensitivity and produce intrauterine growth retardation in children.

Detailed description

PROTOCOL OUTLINE: Patients undergo blood draw. Insulin-like growth factor-I (IGF-I) and insulin-like growth factor binding protein-3 (IGFBP-3) are measured. Patients whose IGF-I and IGFBP-3 levels are average or above are tested for the presence of mutation in the insulin-like growth factor-I receptor.

Conditions

Timeline

Start date
1997-01-01
First posted
2000-04-07
Last updated
2005-06-24

Locations

5 sites across 1 country: United States

Source: ClinicalTrials.gov record NCT00005105. Inclusion in this directory is not an endorsement.